Table 3. Newly Identified HIV Infection Among Participants and Social Network Members Who Used Study Self-testsa.
| Reporting Interval | No. (%) | P Valueb | Survey | Social Network Members, No. (%) | |
|---|---|---|---|---|---|
| Self-testing | Control | ||||
| Day 1 to 3 mo | 12/1325 (0.91) | 2/1340 (0.15) | .007 | 3 mo | 11/710 (1.55) |
| >3-6 mo | 3/1313 (0.23) | 1/1338 (0.07) | .37 | 6 mo | 8/541 (1.48) |
| >6-9 mo | 5/1310 (0.38) | 5/1337 (0.37) | .99 | 9 mo | 8/512 (1.56) |
| >9 mo to end of trial | 5/1305 (0.38) | 3/1332 (0.23) | .50 | 12 mo | 7/559 (1.25) |
| Day 1 to end of trial | 25/1325 (1.88) | 11/1340 (0.82) | .02 | All surveys | 34/2152 (1.58) |
a
Includes all reported infections: participant-reported infections and Centers for Disease Control and Prevention laboratory-diagnosed infections.
b
Fisher exact test between self-testing and control groups.